Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4I8I9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.698 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.548 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.538 |
CLV_PCSK_FUR_1 | 130 | 134 | PF00082 | 0.694 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.701 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.489 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.460 |
DOC_CYCLIN_yCln2_LP_2 | 53 | 59 | PF00134 | 0.620 |
DOC_MAPK_gen_1 | 123 | 131 | PF00069 | 0.660 |
DOC_MAPK_gen_1 | 44 | 53 | PF00069 | 0.525 |
DOC_MAPK_MEF2A_6 | 44 | 53 | PF00069 | 0.517 |
DOC_MAPK_NFAT4_5 | 46 | 54 | PF00069 | 0.597 |
DOC_MAPK_RevD_3 | 24 | 38 | PF00069 | 0.554 |
DOC_PP1_RVXF_1 | 65 | 72 | PF00149 | 0.497 |
DOC_PP1_RVXF_1 | 79 | 86 | PF00149 | 0.449 |
DOC_USP7_UBL2_3 | 105 | 109 | PF12436 | 0.602 |
DOC_USP7_UBL2_3 | 119 | 123 | PF12436 | 0.641 |
DOC_USP7_UBL2_3 | 44 | 48 | PF12436 | 0.534 |
DOC_WW_Pin1_4 | 52 | 57 | PF00397 | 0.533 |
DOC_WW_Pin1_4 | 94 | 99 | PF00397 | 0.475 |
LIG_FHA_2 | 106 | 112 | PF00498 | 0.761 |
LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.503 |
LIG_SH3_3 | 19 | 25 | PF00018 | 0.517 |
MOD_CK2_1 | 105 | 111 | PF00069 | 0.722 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.509 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.595 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.481 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.568 |
MOD_PKA_1 | 12 | 18 | PF00069 | 0.552 |
MOD_ProDKin_1 | 52 | 58 | PF00069 | 0.532 |
MOD_ProDKin_1 | 94 | 100 | PF00069 | 0.482 |
MOD_SUMO_rev_2 | 64 | 69 | PF00179 | 0.539 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.502 |
TRG_ER_diArg_1 | 129 | 132 | PF00400 | 0.760 |
TRG_ER_diArg_1 | 6 | 9 | PF00400 | 0.444 |
TRG_NLS_MonoExtC_3 | 36 | 41 | PF00514 | 0.595 |
TRG_NLS_MonoExtN_4 | 9 | 15 | PF00514 | 0.549 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HXE6 | Leptomonas seymouri | 74% | 100% |
A0A0S4IS54 | Bodo saltans | 67% | 84% |
A0A1X0NSL1 | Trypanosomatidae | 68% | 100% |
A0A3S5H7T4 | Leishmania donovani | 99% | 100% |
A0A422P317 | Trypanosoma rangeli | 68% | 100% |
A4HL08 | Leishmania braziliensis | 82% | 100% |
D0AAM8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 76% | 100% |
E9B3E9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q4Q1 | Leishmania major | 91% | 100% |
V5DME8 | Trypanosoma cruzi | 67% | 100% |